MedPath

A trial comparing conventional fractionation with 'CHART' in the radical treatment of non-small cell carcinoma of the bronchus

Not Applicable
Completed
Conditions
Cancer
Non-small cell carcinoma of the bronchus
Registration Number
ISRCTN74298211
Lead Sponsor
Medical Research Council (MRC) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
600
Inclusion Criteria

Inoperable non-small cell carcinoma of the bronchus confined to the thorax proven by histology or by unequivocal brush cytology

Exclusion Criteria

1. There should be no evidence of distant metastases including supraclavicular nodes;
2. The patient must have no evidence of a pleural effusion unless it can be attributed to a recent surgical intervention;
3. The volume of the site of tumour within the thorax should be such that a radical course of radiotherapy could be given without prejudicing vital structures such as the spinal cord or lung

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath